ArticleDEN open2026
Five Cases of Hepatic Mesenchymal Tumors Diagnosed by Endoscopic Ultrasound-Guided Tissue Acquisition.
Article in DEN open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous biopsy remains the gold standard for diagnosing focal liver lesions; however, endoscopic ultrasound-guided tissue acquisition (EUS-TA) has recently emerged as a promising alternative. Although its diagnostic performance is favorable, most available evidence has focused on epithelial tumors, and reports on mesenchymal tumors are rare. Herein, we report five cases of hepatic mesenchymal tumors diagnosed using EUS-TA. The cohort comprised four male and one female patient, with a median age of 70 years (range, 63-88). The median targeted lesion size was 30 mm (range, 22-61 mm), predominantly located in the left lateral hepatic segments. Four cases underwent transgastric biopsy and one transduodenal biopsy, using either a 22-gauge aspiration or biopsy needle. All procedures were technically successful, and no procedure-related adverse events occurred. Histopathological examination established definitive diagnoses of leiomyosarcoma (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.